Rhoen Klinikum (ETR:RHK) has been given a €25.00 ($29.07) price target by analysts at Commerzbank in a research note issued to investors on Friday. The brokerage presently has a “neutral” rating on the stock. Commerzbank’s target price would indicate a potential upside of 7.57% from the company’s previous close.
Several other research analysts have also recently commented on the stock. Berenberg Bank set a €27.75 ($32.27) target price on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a report on Monday, August 6th. Warburg Research set a €25.20 ($29.30) price target on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Friday. Independent Research set a €26.00 ($30.23) price target on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Wednesday, August 8th. Credit Suisse Group set a €19.00 ($22.09) price target on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Monday, August 6th. Finally, Cfra set a €25.00 ($29.07) price target on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Friday, August 3rd. Five analysts have rated the stock with a sell rating and six have given a hold rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of €24.10 ($28.02).
Rhoen Klinikum stock opened at €23.24 ($27.02) on Friday. Rhoen Klinikum has a twelve month low of €25.08 ($29.16) and a twelve month high of €32.12 ($37.35).
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.
Further Reading: Technical Analysis
Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.